Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Declines By 53.3%

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 46,800 shares, a drop of 53.3% from the October 31st total of 100,200 shares. Based on an average trading volume of 504,700 shares, the days-to-cover ratio is presently 0.1 days. Currently, 7.5% of the shares of the stock are short sold.

Analysts Set New Price Targets

Separately, LADENBURG THALM/SH SH initiated coverage on shares of Autonomix Medical in a research note on Tuesday, September 3rd. They set a “buy” rating and a $28.00 price target on the stock.

Autonomix Medical Trading Down 8.5 %

Shares of Autonomix Medical stock opened at $5.49 on Thursday. The company has a 50-day moving average of $11.14 and a two-hundred day moving average of $19.27. Autonomix Medical has a 12-month low of $5.46 and a 12-month high of $152.00. The company has a current ratio of 4.26, a quick ratio of 4.26 and a debt-to-equity ratio of 0.36. The stock has a market cap of $6.32 million and a PE ratio of -0.34.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.